|
Scleroderma is a connective tissue disease, the origin of which is unknown, characterized by fibrosis, or
thickening by scar tissue, of the skin and sometimes internal organs. Since many of the patients have autoantibodies in the blood it is considered an autoimmune disorder. Almost all patients with scleroderma
have Raynauds phenomenon and with exposure to cold temperature their fingers and sometimes toes become painful and turn first white, then blue and red. Scleroderma can be divided into those with limited skin
involvement or those with more generalized skin involvement. Limited skin disease can be accompanied by additional features including skin Calcinosis, Raynauds phenomenon, abnormalities of the Esophagus (food
pipe), Sclerodactyly (tightening of skin on the fingers) and skin Telangiectasias (spider veins). This type of scleroderma is referred to as CREST syndrome. Patients with diffuse, generalized skin
fibrosis may have the type of sclerodenna known as systemic sclerosis and may develop fibrosis involving the lungs, heart, gastrointestinal tract and kidneys. At HJDOI we have a team of physicians including rheumatologists, pulmonary specialists, and a nephrologist familiar with the diagnosis and treatment of scleroderma. We
offer a variety of medical management intended to treat the autoimmune condition or relieve the various symptoms that may lead to disability or impairment. Rheumatologists are expert at using traditional therapies
for scieroderma such as d-penicillamine, histamine blockers, proton pump inhibitors, calcium antagonists, and angiotensin converting enzyme inhibitors. Our rheumatologists will also provide access to appropriate
specialists in other disciplines when necessary, coordinate care in concert with your primary care physician and discuss experimental treatments such as relaxin as they become available. Call for an appointment at the Faculty Practice Office: (212) 598-6516 or The General Arthritis Clinic: (212) 598-6321 or 6322. |
|
